PRNB

Principia Biopharma Inc. Common Stock
PRNB

Overview Fund Activity
Delisted

PRNB was delisted on the 25th of September, 2020.

Back to rankings

74 hedge funds and large institutions have $671M invested in Principia Biopharma Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 30 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
+12
Holders Change %
+19.35%
% of All Funds
1.61%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
25
Increased
30
Reduced
11
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PHS
PFM Health Sciences
California
+$19.7M
2
BlackRock
BlackRock
New York
+$17.8M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$9.45M
4
RG
Redmile Group
California
+$8.1M
5
State Street
State Street
Massachusetts
+$5.08M

Top Sellers

1
O
OrbiMed
New York
-$33.2M
2
Bank of America
Bank of America
North Carolina
-$10.5M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$6.64M
4
RI
RTW Investments
New York
-$6.14M
5
PC
Polar Capital
United Kingdom
-$2.55M
Name Holding Trade Value Shares
Change 		Shares
Change %
Marshall Wace
76
Marshall Wace
United Kingdom
– -$1.97M -57,934 Closed
Invesco
77
Invesco
Georgia
– -$825K -24,256 Closed
MWNA
78
Marshall Wace North America
New York
– -$603K -17,717 Closed
OAM
79
Oxford Asset Management
United Kingdom
– -$595K -17,501 Closed
ECM
80
ExodusPoint Capital Management
New York
– -$550K -16,177 Closed
SO
81
STRS Ohio
Ohio
– -$163K -4,800 Closed
Royal Bank of Canada
82
Royal Bank of Canada
Ontario, Canada
– -$17K -500 Closed
Federated Hermes
83
Federated Hermes
Pennsylvania
– -$10K -304 Closed
CCA
84
Catalyst Capital Advisors
New York
– -$7K -210 Closed
1 2 3
4